Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 Nov 14;113(3):660–669. doi: 10.1002/cpt.2768

Figure 1.

Figure 1

Simulated lumefantrine concentration over time for patients with and without ART. The lines represent the median predicted lumefantrine concentration and the shaded regions represent the 30% prediction interval (i.e., from the 35th to 65th percentiles) of the median. ART, antiretroviral therapy; EFV, efavirenz.